A Commentary on "Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes".

Neurospine · 2025 · PMC12010862 · PMID 40211518

Europe PMC DOI

hedged sentence

0.1900

closest p · 3.8× alpha

0.1900

boldest claim

The sentences

showed a trendp= 0.190not close (p > 0.1)

Total hip BMD change also showed a trend toward greater improvement with romosozumab compared to vertebroplasty (p= 0.190).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.